WEBINARS
Our webinars allow users to learn from experts and earn continuing education credits on industry topics, progress in research, services available, and more.
Show More
Sebia, Inc.
Sebia is the world's leading provider of clinical protein electrophoresis equipment and reagents, a technology used for in-vitro diagnostic (IVD) testing. Its systems analyze proteins in order to screen and monitor various diseases and conditions; primarily oncology (Multiple Myeloma), metabolic disorders such as Diabetes and also Hemoglobinopathy and rare pathologies.
Show More
-
MAR 11, 2025 | 9:00 AMC.E. CREDITS
Serum free light chain (sFLC) tests have advanced the prediction, diagnosis, and monitoring of plasma cell disorders. This webinar features two leading experts who will compare the performan... -
NOV 13, 2024 | 10:00 AMC.E. CREDITS
Capillary Electrophoresis is one of the newer methods for the detection and evaluation of hemoglobinopathies. It improves upon the alkaline gel electrophoresis platform with a similar migrat...
-
SEP 18, 2024 | 9:00 AMC.E. CREDITS
abstract Learning Objectives Understand how the health disparity affects ordering M-protein testing at the right time. Discuss Analytical considerations of the test panel/methods ordered Ide...
-
JUL 17, 2024 | 12:00 PMC.E. CREDITS
Recently, the American Association of Clinical Chemistry (AACC), now Association of Diagnostics & Laboratory Medicine (ADLM), in collaboration with the American Diabetes Association (ADA...
AUG 01, 2023 | 9:00 AM
C.E. CREDITS
Testing for abnormal immunoglobulins was based previously on serum electrophoresis and immunofixation only. In the last years, however, free light chain (FLC) testing in serum became one imp...
MAR 30, 2023 | 8:00 AM
C.E. CREDITS
Date: March 30, 2023 Time: 8:00am (PDT), 11:00am (EDT), 5:00pm (CEST) Advances and innovations in laboratory technologies for performing protein electrophoresis and immunotyping, combined wi...
FEB 09, 2023 | 9:00 AM
Date: February 09, 2023 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Monoclonal gammopathies (MGs) comprise a broad set of diseases involving the abnormal clonal proliferation of plasma c...
NOV 09, 2022 | 9:00 AM
Date: November 09, 2022 Time: 9:00am (PST), 12:00pm (EST), 6:00pm (CET) Hemoglobin A1c is used clinically as a biomarker for the diagnosis and management of diabetes mellitus. Various method...
OCT 26, 2021 | 9:00 AM
Date: October 26, 2021 Time: 9:00am (PDT), 12:00pm (EDT) Capillary Electrophoresis plays an important role in the diagnosis of hemoglobinopathy carriers and patients. The general flow is the...
JUN 15, 2021 | 9:00 AM
Date: June 15, 2021 Time: 9:00am PDT HbA1c is routinely used in the clinical laboratory to diagnose and monitor diabetes mellitus. Many methods have been standardized to provide precise and...
DEC 04, 2020 | 8:00 AM
DATE: December 4th, 2020 TIME: 8:00am PT With many methods available for HbA1c testing, how do you choose a method that’s best for your laboratory? The incidence and prevalence of diab...
DEC 05, 2017 | 10:00 AM
DATE: December 5, 2017TIME: 10:00AM PT, 1:00PM ET Monoclonal Gammopathies (MG) are characterized by chromosomal aberration of B-cells or plasma cells resulting in benign or mal...
-
MAR 31, 2025The Thomas Experts Series & The Thomas Center Labs
-
APR 02, 2025Bioprocessing Virtual Event Series 2025
-
APR 03, 2025OncomineWorld 2025: A virtual NGS education meeting
-
APR 16, 2025Cannabis Sciences Virtual Event Series 2025
-
APR 21, 2025Stago EdVantage Virtual University
- See More
-
MAR 17, 2025
-
MAR 13, 2025
-
MAR 20, 2025
- See More
